AMETEK, Inc. (NYSE:AME) Shares Sold by Signature Wealth Management Partners LLC

Signature Wealth Management Partners LLC lessened its holdings in AMETEK, Inc. (NYSE:AMEFree Report) by 0.4% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 34,055 shares of the technology company’s stock after selling 153 shares during the period. AMETEK accounts for about 4.3% of Signature Wealth Management Partners LLC’s portfolio, making the stock its 6th biggest position. Signature Wealth Management Partners LLC’s holdings in AMETEK were worth $5,677,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of AMETEK by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 25,578,270 shares of the technology company’s stock worth $4,217,601,000 after buying an additional 84,832 shares during the last quarter. JPMorgan Chase & Co. boosted its position in AMETEK by 48.4% in the 1st quarter. JPMorgan Chase & Co. now owns 7,075,565 shares of the technology company’s stock worth $1,294,121,000 after purchasing an additional 2,306,535 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of AMETEK by 0.7% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,536,231 shares of the technology company’s stock worth $1,195,478,000 after purchasing an additional 44,899 shares during the period. Capital International Investors increased its holdings in shares of AMETEK by 5.0% during the 4th quarter. Capital International Investors now owns 4,196,755 shares of the technology company’s stock valued at $692,051,000 after purchasing an additional 198,777 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of AMETEK in the 4th quarter valued at $589,098,000. 87.43% of the stock is owned by hedge funds and other institutional investors.

AMETEK Price Performance

Shares of AMETEK stock traded up $1.26 during mid-day trading on Monday, reaching $160.78. 2,157,291 shares of the stock traded hands, compared to its average volume of 1,135,204. The stock has a market capitalization of $37.22 billion, a PE ratio of 28.26, a PEG ratio of 2.57 and a beta of 1.18. The business has a 50-day moving average of $167.59 and a 200 day moving average of $172.43. AMETEK, Inc. has a fifty-two week low of $136.89 and a fifty-two week high of $186.32. The company has a quick ratio of 0.66, a current ratio of 1.26 and a debt-to-equity ratio of 0.20.

AMETEK (NYSE:AMEGet Free Report) last posted its quarterly earnings data on Thursday, August 1st. The technology company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.64 by $0.02. AMETEK had a return on equity of 17.41% and a net margin of 19.51%. The firm had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.78 billion. During the same period in the prior year, the company earned $1.57 EPS. The firm’s revenue was up 5.4% compared to the same quarter last year. On average, analysts predict that AMETEK, Inc. will post 6.78 EPS for the current year.

AMETEK Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a dividend of $0.28 per share. The ex-dividend date is Monday, September 16th. This represents a $1.12 dividend on an annualized basis and a yield of 0.70%. AMETEK’s payout ratio is presently 19.68%.

Wall Street Analysts Forecast Growth

AME has been the topic of several analyst reports. StockNews.com lowered shares of AMETEK from a “buy” rating to a “hold” rating in a research report on Tuesday, August 6th. TD Cowen cut their price target on AMETEK from $165.00 to $158.00 and set a “hold” rating for the company in a research note on Monday, August 5th. Truist Financial lowered their price target on AMETEK from $204.00 to $201.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd. Robert W. Baird dropped their price objective on AMETEK from $171.00 to $166.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Finally, Oppenheimer raised AMETEK from a “market perform” rating to an “outperform” rating and set a $200.00 target price for the company in a research note on Wednesday, May 22nd. Four investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $186.29.

Check Out Our Latest Stock Analysis on AME

Insider Activity at AMETEK

In other AMETEK news, Director Steven W. Kohlhagen sold 1,440 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $173.93, for a total value of $250,459.20. Following the transaction, the director now directly owns 24,809 shares of the company’s stock, valued at approximately $4,315,029.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Steven W. Kohlhagen sold 1,440 shares of the stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $173.93, for a total value of $250,459.20. Following the completion of the sale, the director now owns 24,809 shares of the company’s stock, valued at $4,315,029.37. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Steven W. Kohlhagen sold 1,470 shares of the company’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $170.20, for a total value of $250,194.00. Following the completion of the sale, the director now owns 26,249 shares of the company’s stock, valued at $4,467,579.80. The disclosure for this sale can be found here. 0.61% of the stock is owned by corporate insiders.

About AMETEK

(Free Report)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Featured Stories

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.